ConductScience.org, home

Paper28147705

"It's about my life": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa.

Jacobson KB and 4 others. AIDS Care, 2017. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. "It's about my life": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa. Papers, record 28147705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28147705

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
"It's about my life": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa.
PubMed
Journal
AIDS Care
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
2.27
iCite
Revised in PubMed
2026-01-27
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jacobson KBKaren Bhttps://orcid.org/0000-0003-3050-4595
2Niccolai LLinda
3Mtungwa NNonhlehttps://orcid.org/0000-0001-9958-3864
4Moll APAnthony P
5Shenoi SVSheela Vhttps://orcid.org/0000-0001-7654-4344

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AIDS-Related Opportunistic InfectionsMajor topic
Antitubercular AgentsMajor topic
HIV InfectionsMajor topic
Health Knowledge, Attitudes, PracticeMajor topic
IsoniazidMajor topic
Patient ComplianceMajor topic
TuberculosisMajor topic
Adult
Ambulatory Care Facilities
Counseling
Female
Health Services Accessibility
Humans
Incidence
Interviews as Topic
Male
Qualitative Research
Rural Population
Social Stigma
South Africa
Trust

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K23 AI089260NIAID NIH HHSUnited StatesK23AI089260PubMed and NIHNIH RePORTER
P30 MH062294NIMH NIH HHSUnited StatesP30MH062294PubMed and NIHNIH RePORTER
T32 AI007517NIAID NIH HHSUnited StatesT32AI007517PubMed and NIHNIH RePORTER
UL1 TR001863NCATS NIH HHSUnited StatesUL1TR001863PubMed and NIHNIH RePORTER

Download CSV of grants

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122221424Adherence to isoniazid preventive therapy in Indonesian children: A quantitative and qualitative investigation.BMC Res Notes2012https://conductscience.org/library/papers/22221424PubMed
223285064A recent HIV diagnosis is associated with non-completion of Isoniazid Preventive Therapy in an HIV-infected cohort in Cape Town.PLoS One2012https://conductscience.org/library/papers/23285064PubMed
320299958Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting.AIDS2010https://conductscience.org/library/papers/20299958PubMed
421079427Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study.AIDS2010https://conductscience.org/library/papers/21079427PubMed
510625273Qualitative research in health care. Analysing qualitative data.BMJ2000https://conductscience.org/library/papers/10625273PubMed
615786888Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings?Int J Tuberc Lung Dis2005https://conductscience.org/library/papers/15786888PubMed
79110083Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand.AIDS1997https://conductscience.org/library/papers/9110083PubMed
816772037Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.BMC Infect Dis2006https://conductscience.org/library/papers/16772037PubMed
925035943Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa.Glob Public Health2014https://conductscience.org/library/papers/25035943PubMed
1024498298Factors associated with adherence to treatment with isoniazid for the prevention of tuberculosis amongst people living with HIV/AIDS: a systematic review of qualitative data.PLoS One2014https://conductscience.org/library/papers/24498298PubMed
1117676945Patient adherence to tuberculosis treatment: a systematic review of qualitative research.PLoS Med2007https://conductscience.org/library/papers/17676945PubMed
1221079428The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study.AIDS2010https://conductscience.org/library/papers/21079428PubMed
1323651743Isoniazid preventive treatment: predictors of adverse events and treatment completion.Int J Tuberc Lung Dis2013https://conductscience.org/library/papers/23651743PubMed
1421079425Adverse events with isoniazid preventive therapy: experience from a large trial.AIDS2010https://conductscience.org/library/papers/21079425PubMed
1520091503Treatment of latent tuberculosis infection in HIV infected persons.Cochrane Database Syst Rev2010https://conductscience.org/library/papers/20091503PubMed
1622151609Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia.BMC Public Health2011https://conductscience.org/library/papers/22151609PubMed
1722583688Survey of isoniazid preventive therapy in South Africa, 2011.Int J Tuberc Lung Dis2012https://conductscience.org/library/papers/22583688PubMed
1821541021Risk factors for non-adherence and loss to follow-up in a three-year clinical trial in Botswana.PLoS One2011https://conductscience.org/library/papers/21541021PubMed

Download CSV of references

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
42963049Tuberculosis preventive treatment and care cascade among household contacts of patients starting tuberculosis treatment in Southern Africa: a multicountry cohort analysis.BMJ Glob Health2026https://conductscience.org/library/papers/42963049PubMed
42646802Understanding Barriers to Uptake of TB Preventive Treatment Among People Living with HIV in Zimbabwe: A Qualitative Assessment of Healthcare Workers' Perspectives.Trop Med Infect Dis2026https://conductscience.org/library/papers/42646802PubMed
42466460
'Why should I start medication when I am not feeling sick?' A qualitative study of refusal, initiation, completion and discontinuation of tuberculosis preventive treatment among people living with HIV in sub-Saharan Africa.
BMJ Public Health2026https://conductscience.org/library/papers/42466460PubMed
42134798Co-Occurring Risk Factors for Tuberculosis Preventive Treatment Non-Adherence Among People Living With HIV in Ethiopia: A Latent Class Analysis.Trop Med Int Health2026https://conductscience.org/library/papers/42134798PubMed
41488695Analysis of Tuberculosis Preventive Treatment Cascade Among People With Human Immunodeficiency Virus in Georgia: A Mixed-Methods Study.Open Forum Infect Dis2026https://conductscience.org/library/papers/41488695PubMed
41441584Optimization of Case Finding and Preventive Treatment Among Household Contacts of People with Tuberculosis in Zimbabwe.Trop Med Infect Dis2025https://conductscience.org/library/papers/41441584PubMed
41100456TB will never end because of us: Experiences of TB preventive treatment among people living with HIV/AIDS in South Africa.PLoS One2025https://conductscience.org/library/papers/41100456PubMed
41005953'And the stick to fight TB is TPT': nurse-identified barriers and facilitators of tuberculosis preventive therapy implementation in rural South Africa.BMJ Open Respir Res2025https://conductscience.org/library/papers/41005953PubMed
40055618Evaluating community knowledge of tuberculosis preventive therapy in rural South Africa.BMC Public Health2025https://conductscience.org/library/papers/40055618PubMed
39953814Perceived HBV-Related Stigma Is Associated With Lower Antiviral Medication Adherence in Patients With Chronic Hepatitis B.J Viral Hepat2025https://conductscience.org/library/papers/39953814PubMed
39953433A systematic review exploring the role of tuberculosis stigma on test and treatment uptake for tuberculosis infection.BMC Public Health2025https://conductscience.org/library/papers/39953433PubMed
39733063Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review.Drugs2025https://conductscience.org/library/papers/39733063PubMed
39728828
Acceptance and Completion Rates of 3-Month Isoniazid-Rifampicin (3HR) Tuberculosis Preventive Treatment (TPT) Among Contacts of Bacteriologically Confirmed TB Patients-Patients' and Healthcare Workers' Perspectives.
Trop Med Infect Dis2024https://conductscience.org/library/papers/39728828PubMed
39210349
Facilitators and barriers to initiating and completing tuberculosis preventive treatment among children and adolescents living with HIV in Uganda: a qualitative study of adolescents, caretakers and health workers.
AIDS Res Ther2024https://conductscience.org/library/papers/39210349PubMed
38966799Loss to follow-up among people living with HIV on tuberculosis preventive treatment at four regional referral hospitals, Uganda, 2019-2021.J Clin Tuberc Other Mycobact Dis2024https://conductscience.org/library/papers/38966799PubMed
37231600Understanding patient-level costs of weekly isoniazid-rifapentine (3HP) among people living with HIV in Uganda.Int J Tuberc Lung Dis2023https://conductscience.org/library/papers/37231600PubMed
36962910Community-based referral for tuberculosis preventive therapy is effective for treatment completion.PLOS Glob Public Health2022https://conductscience.org/library/papers/36962910PubMed
36821550
Increased uptake of tuberculosis preventive therapy (TPT) among people living with HIV following the 100-days accelerated campaign: A retrospective review of routinely collected data at six urban public health facilities in Uganda.
PLoS One2023https://conductscience.org/library/papers/36821550PubMed
36561901Reasons for poor uptake of TB preventive therapy in South Africa.Public Health Action2022https://conductscience.org/library/papers/36561901PubMed
36434517Assessment of contextual factors shaping delivery and uptake of isoniazid preventive therapy among people living with HIV in Dar es salaam, Tanzania.BMC Infect Dis2022https://conductscience.org/library/papers/36434517PubMed

See all 42 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28147705

GET https://conductscience.org/api/papers/v1/28147705/cited_by?page=2